Reports
Sale
Global Artificial Pancreas Device Systems Market: By Device Type: Threshold Suspend Device Systems, Control-to-Range (CTR) Systems, Control-to-Target (CTT) Systems; By End User: Clinics, Others; Regional Analysis; Market Dynamics: SWOT Analysis, Porter’s Five Forces Model, Key Demand Indicators; Supplier Landscape; 2024-2032
Global Artificial Pancreas Device Systems Market Size
The global artificial pancreas device systems market was valued at USD 653.81 million in 2023, driven by increasing prevalence of diabetes across the globe. The market is expected to grow at a CAGR of 20% during the forecast period of 2024-2032, with the values likely to reach USD 3,314.1 million by 2032.
Global Artificial Pancreas Device Systems Market Outlook
In April 2023, Medtronic received the US FDA approval for its MiniMed™ 780G artificial pancreas system for use in individuals 7 years and over. Rising product approvals are expected to the boost the market value in the forecast period.
The market is witnessing the emergence of several technically advanced products. In May 2023, Beta Bionics, Inc., announced FDA 510(k) clearance and the commercial launch of the iLet bionic pancreas. The iLet bionic pancreas is the first and only automated insulin-delivery system. Moreover, the device can be paired with the Dexcom G6 Continuous Glucose Monitoring System.
Based on region, North America is expected to hold a significant market share in the forecast period.
Global Artificial Pancreas Device Systems Market Overview
Artificial pancreas also referred as closed-loop system, an automated insulin delivery system, or an autonomous system mimics the blood glucose regulation of a healthy pancreas. Mostly, an artificial pancreas consists of three parts, namely, continuous glucose monitor (CGM), automatic insulin delivery system, and controller/control algorithm which regulates the administration of insulin in response to current blood glucose measurements. The device is vital for the patients mainly with type 1 diabetes as they lack the tendency to produce the insulin to regulate blood glucose level. However, the device is also useful for patients with type 2 diabetes who inject insulin occasionally.
As per the latest data from the International Diabetes Federation 2022, nearly 537 million adults ( aged 20-79 years) are living with diabetes, which indicates that every 1 in 10 person is found to affected with diabetes. As per the same source, it is predicted that nearly 643 million people will be affected with the disease by 2030 and 783 million by 2045. Moreover, the market is also driven by the unhealthy lifestyle and obesity that can result into diabetes at later stages.
Global Artificial Pancreas Device Systems Market Growth Drivers
Increasing Diabetes Prevalence to Propel the Market Value Significantly
According to the International Diabetes Federation 2022, about 1.52 million people under the age of 20 are living with the type 1 diabetes globally. The World health Organization (WHO) estimates shows that diabetes is directly responsible for 1.5 million fatalities worldwide each year. In order to manage the condition effectively, it is crucial to constantly balance giving appropriate amount of insulin along with monitoring blood glucose levels. As a result, the usage of artificial pancreas is on the rise, envisioned to mitigate the comorbidities associated with the chronic condition.
Growing Obesity Rates are Projected to Boost Artificial Pancreas Device Systems Market Demand
According to the World Health Organization (WHO), around 2.5 billion adults (18 years or older) were overweight, out of which around 890 million adults were living with obesity in 2022. This equates to about 43% of the adults being overweight, which shows an increase from 1990 when 25% of adults aged 18 years and above were overweight. A study conducted on 128,571 individuals from the United States, during 2016 to 2021 indicated that 34% of adults with type 1 diabetes were overweight, while 28% had obesity. Clearly, obesity is the main risk factor for diabetes and can contribute to nearly half of the patient with diabetes.
Global Artificial Pancreas Device Systems Market Trends
The market is witnessing several trends and developments to improve the current global scenario. Some of the notable trends are as follows:
| Key Trends | Impact |
| Technological Advancements | For a diabetic patient, it is necessary to maintain the dose titration and timely injection in order to maintain the optimal glycemic control. However, in recent years technological advancements have led to the integration of CGM and insulin pumps in one device. This has created paradigm shifts in the management of diabetes patient with the development of artificial pancreas. |
| Increased Research and Initiatives by Institutions | Continuous research and collaboration by organizations has revolutionized the management of diabetes with artificial pancreas. For instance, FDA is contributing to the development of an artificial pancreas device system by prioritizing the review of research protocol studies defining performance and safety standards. It is also working on guiding the industry with clear guidelines, encouraging collaboration between public and private researchers, co-sponsoring public forums, and figuring out ways to reduce study and review times. |
| Clinical Evidence | Adoption of artificial pancreas device system is being fueled by mounting clinical evidence for its safety and efficacy. Studies have shown that artificial pancreas device system users have significant improvements in glycemic control, decrease in the frequency of hypoglycemia, and an improvement in their quality of life. |
| Integration with Mobile Devices and Apps | Manufacturers are trying to integrate artificial pancreas in mobiles or applications that can allow the patients to quickly check their glucose levels, receive alerts and notification. Such facilities may prove to be beneficial for patients while providing better experience. |
Global Artificial Pancreas Device Systems Market Segmentation
Market Breakup by Device Type
- Threshold Suspend Device Systems
- Control-to-Range (CTR) Systems
- Control-to-Target (CTT) Systems
Market Breakup by End User
- Hospitals
- Clinics
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Artificial Pancreas Device Systems Market Share
Market Segmentation Based on Device Type is Anticipated to Witness Substantial Growth
Based on device type, the market segmentation includes threshold suspend device systems, control-to-range (CTR) Systems, and control-to-target (CTT) systems. Threshold suspend device system can automatically suspend the insulin delivery if the blood glucose level gets low. Moreover, the control-to-range (CTR) seek to keep blood glucose levels within a specified target range in response to the CGM. While the control-to-target (CTT) systems provide the specific glucose levels that are set by healthcare providers. The type of device used may differ, based on the diverse needs of individuals with diabetes.
Global Artificial Pancreas Device Systems Market Analysis by Region
Regionally, the market report offers an insight into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America and Europe are likely to hold a significant market share, which can be attributed a well-established infrastructure that can technological advancements along with increasing incidence of diabetic patients. Growing collaborations between academic institutions and MedTech companies is also poised to boost research initiatives and fuel the region’s market growth.
Asia Pacific is projected to witness substantial growth. It can be accredited to increasing number of diabetic patients due to changing lifestyles and increasing initiatives by the government.
Leading Players in the Global Artificial Pancreas Device Systems Market
The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Medtronic
- EOFLOW CO., LTD
- Beta Bionics
- Tandem Diabetes Care, Inc.
- Insulet Corporation
- Dexcom
- Medtrum Technologies Inc.
- Nikkiso Co., Ltd.
- Pancreum, Inc.
- Abbott
- Admetsys Corporation
- INREDA® DIABETIC B.V.
- Diabeloop SA
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Device Type |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Key Questions Answered in the Global Artificial Pancreas Device Systems Market Report
- What was the global artificial pancreas device systems market value in 2023?
- What is the global artificial pancreas device systems market forecast outlook for 2024-2032?
- What are the regional markets covered in the EMR report?
- What is market segmentation based on product type?
- Who are the major end users in the market?
- What are the major factors aiding the global artificial pancreas device systems market demand?
- How has the artificial pancreas device systems market performed so far and how is it anticipated to perform in the coming years?
- What are the major market trends influencing the market?
- What are the market's major drivers, opportunities, and restraints?
- Which regional market is expected to lead the market share in the forecast period?
- Which country is expected to experience expedited growth during the forecast period?
- How does the prevalence of diabetes affect the market landscape?
- How does the rise in the obesity impact the market size?
- Which device type will dominate the market share?
- How does the rise in the geriatric population impact the market size?
- Which region is expected to have a high market value in the coming years?
- Which end-user will experience the highest demand in the market segment?
- Who are the key players involved in the artificial pancreas device systems market?
- What is patent landscape of the market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers and acquisitions among the key market players shaping the market dynamics?
Artificial Pancreas Device Systems Market Report Snapshots
Artificial Pancreas Device Systems Market Size
Artificial Pancreas Device Systems Market Growth
Artificial Pancreas Device Systems Market Trends
Artificial Pancreas Device Systems Market Share
Artificial Pancreas Device Systems Market Regional Analysis
Artificial Pancreas Device Systems Companies
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Artificial Pancreas Device Systems Market Overview
3.1 Global Artificial Pancreas Device Systems Market Historical Value (2017-2023)
3.2 Global Artificial Pancreas Device Systems Market Forecast Value (2024-2032)
4 Global Artificial Pancreas Device Systems Market Landscape*
4.1 Global Artificial Pancreas Device Systems Market: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Artificial Pancreas Device Systems Market: Product Landscape
4.2.1 Analysis by Device Type
5 Global Artificial Pancreas Device Systems Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Model
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Artificial Pancreas Device Systems Market Segmentation (2017-2032)
6.1 Global Artificial Pancreas Device Systems Market (2017-2032) by Device Type
6.1.1 Market Overview
6.1.2 Threshold Suspend Device Systems
6.1.3 Control-to-Range (CTR) Systems
6.1.4 Control-to-Target (CTT) Systems
6.2 Global Artificial Pancreas Device Systems Market (2017-2032) by End User
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Others
6.3 Global Artificial Pancreas Device Systems Market (2017-2032) by Region
6.3.1 Market Overview
6.3.2 North America
6.3.3 Europe
6.3.4 Asia Pacific
6.3.5 Latin America
6.3.6 Middle East and Africa
7 North America Artificial Pancreas Device Systems Market (2017-2032)
7.1 North America Artificial Pancreas Device Systems Market (2017-2032) by Device Type
7.1.1 Market Overview
7.1.2 Threshold Suspend Device Systems
7.1.3 Control-to-Range (CTR) Systems
7.1.4 Control-to-Target (CTT) Systems
7.2 North America Artificial Pancreas Device Systems Market (2017-2032) by End User
7.2.1 Hospitals
7.2.2 Clinics
7.2.3 Others
7.3 North America Artificial Pancreas Device Systems Market (2017-2032) by Country
7.3.1 United States of America
7.3.2 Canada
8 Europe Artificial Pancreas Device Systems Market (2017-2032)
8.1 Europe Artificial Pancreas Device Systems Market (2017-2032) by Device Type
8.1.1 Market Overview
8.1.2 Threshold Suspend Device Systems
8.1.3 Control-to-Range (CTR) Systems
8.1.4 Control-to-Target (CTT) Systems
8.2 Europe Artificial Pancreas Device Systems Market (2017-2032) by End User
8.2.1 Hospitals
8.2.2 Clinics
8.2.3 Others
8.3 Europe Artificial Pancreas Device Systems Market (2017-2032) by Country
8.3.1 United Kingdom
8.3.2 Germany
8.3.3 France
8.3.4 Italy
8.3.5 Others
9 Asia Pacific Artificial Pancreas Device Systems Market (2017-2032)
9.1 Asia Pacific Artificial Pancreas Device Systems Market (2017-2032) by Device Type
9.1.1 Market Overview
9.1.2 Threshold Suspend Device Systems
9.1.3 Control-to-Range (CTR) Systems
9.1.4 Control-to-Target (CTT) Systems
9.2 Asia Pacific Artificial Pancreas Device Systems Market (2017-2032) by End User
9.2.1 Hospitals
9.2.2 Clinics
9.2.3 Others
9.3 Asia Pacific Artificial Pancreas Device Systems Market (2017-2032) by Country
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 ASEAN
9.3.5 Australia
9.3.6 Others
10 Latin America Artificial Pancreas Device Systems Market (2017-2032)
10.1 Latin America Artificial Pancreas Device Systems Market (2017-2032) by Device Type
10.1.1 Market Overview
10.1.2 Threshold Suspend Device Systems
10.1.3 Control-to-Range (CTR) Systems
10.1.4 Control-to-Target (CTT) Systems
10.2 Latin America Artificial Pancreas Device Systems Market (2017-2032) by End User
10.2.1 Hospitals
10.2.2 Clinics
10.2.3 Others
10.3 Latin America Artificial Pancreas Device Systems Market (2017-2032) by Country
10.3.1 Brazil
10.3.2 Argentina
10.3.3 Mexico
10.3.4 Others
11 Middle East and Africa Artificial Pancreas Device Systems Market (2017-2032)
11.1 Middle East and Africa Artificial Pancreas Device Systems Market (2017-2032) by Device Type
11.1.1 Market Overview
11.1.2 Threshold Suspend Device Systems
11.1.3 Control-to-Range (CTR) Systems
11.1.4 Control-to-Target (CTT) Systems
11.2 Middle East and Africa Artificial Pancreas Device Systems Market (2017-2032) by End User
11.2.1 Hospitals
11.2.2 Clinics
11.2.3 Others
11.3 Middle East and Africa Artificial Pancreas Device Systems Market (2017-2032) by Country
11.3.1 Saudi Arabia
11.3.2 United Arab Emirates
11.3.3 Nigeria
11.3.4 South Africa
11.3.5 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Component of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by Year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Product
14.5 Analysis by Funding Institute
14.6 Analysis by Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Component of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Component of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Market Share by Top 5 Companies
17.2 Medtronic
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 EOFLOW CO., LTD
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Beta Bionics
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Tandem Diabetes Care, Inc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Insulet Corporation
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Dexcom
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Medtrum Technologies Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Nikkiso Co., Ltd.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Pancreum, Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Abbott
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Admetsys Corporation
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 INREDA® DIABETIC B.V.
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Diabeloop SA
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
18 Global Artificial Pancreas Device Systems Market – Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Purchase Options 10% off
Call us
Purchase Full Report
Datasheet
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER